Kulkarni Samarth bought CRSP
March 20, 2026 · Form 4 insider transaction
Kulkarni Samarth bought 114,249 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
114,249
Price
$0.00
Total value
N/A
InsiderKulkarni Samarth
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 20, 2026
Filing dateMarch 24, 2026
Shares owned after114,249
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031.; This option was granted on March 20, 2026 with respect to 114,249 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2026.